ArticleGalen medical journal2025
Treatment of Angiomyoblastoma in a Young Lady in Saudi Arabia: A Case Report : Angiomyoblastoma in a Young pLady in Saudi Arabia.
Article in Galen medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Background: Angiomyofibroblastoma (AMFB) is a rare, benign soft tissue tumor that belongs to the mesenchymal tumor category and affects the female genital tract. Aggressive angiomyxoma, a distinct stroma myxoedematous mesenchymal tumor with a significant risk of local recurrences, must be histomorphologically distinguished from AMFB. Radiography and histopathology are used for accurate diagnosis. The treatment depended on the complete surgical excision. Case Presentation: Case Presentation: Herein, we presented a case of a 36-year-old female (P3+0) presented with a left vaginal mass noted two years prior. The radiology report suggested angiomyxoma or myxoid liposarcoma as possible differentials. Surgical resection revealed a benign genital stromal tumor, specifically angiomyofibroblastoma (AMFB). After complete surgical excision, the immunohistochemical analysis supported the diagnosis of angiomyofibroblastoma. Two months postoperatively, an MRI Post-resection images show complete resection with no feasible scar, residual tumour, or recurrence. Conclusion: Conclusion: Our case is rare AMFB. AMFB may be missed when diagnosed with other masses, such as angiomyxoma or myxoid liposarcoma, so we need to do the necessary tests to diagnose and differentiate AMFB accurately from other masses. Ultrasound and MRI are initial diagnostic tools, while histopathology ensures the correct diagnosis. Surgical removal with free margins remains the appropriate treatment. Long-term follow-up is essential to monitor for potential recurrence, though AMFB typically carries an excellent prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.